Skip to main content
. 2021 Sep 30;224(Suppl 4):S343–S351. doi: 10.1093/infdis/jiaa668

Figure 2.

Figure 2.

Hepatitis B surface antigen (HBsAg) prevalence estimates for 2016. Estimates for countries with data and a model or for which data were extrapolated from countries in the same Global Burden of Disease region with available data (all ages). From Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study [27].